Enhanced adverse health effects upon in vivo exposure to multi-walled carbon nanotubes in chronic obstructive pulmonary disease
S. Beyeler (Bern, Switzerland), C. Wotzkow (Bern, Switzerland), A. Sengal (Bern, Switzerland), P. Wick (St. Gallen, Switzerland), S. Tschanz (Bern, Switzerland), B. Haenni (Bern, Switzerland), C. Von Garnier (Bern, Switzerland), F. Blank (Bern, Switzerland)
Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Session: COPD: immune regulation and therapeutic targets
Session type: Thematic Poster
Number: 4240
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Beyeler (Bern, Switzerland), C. Wotzkow (Bern, Switzerland), A. Sengal (Bern, Switzerland), P. Wick (St. Gallen, Switzerland), S. Tschanz (Bern, Switzerland), B. Haenni (Bern, Switzerland), C. Von Garnier (Bern, Switzerland), F. Blank (Bern, Switzerland). Enhanced adverse health effects upon in vivo exposure to multi-walled carbon nanotubes in chronic obstructive pulmonary disease. 4240
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: